| CONTACT: Tracey Reynolds,
Veterinary Marketing Manager,
859/254-1221 |
Neogen acquires UriCon Chewable
Tablet line
LEXINGTON, Ky.,
Dec. 15, 2004 — Neogen Corporation announced that is has expanded
its companion animal product line with the acquisition of the UriCon
Chewable Tablet line from Agri-Labs based in St. Joseph, MO.
UriCon Chewable
Tablets contain phenylpropanolamine hydrochloride (PPA), the most
commonly prescribed treatment for urethral sphincter mechanism incompetence
(USMI) in female dogs. The easy to use and administer UriCon chewables
are much smaller than other PPA tablets—about half the size
of others of the same dosage strength.
“The smaller, double-scored
chewable tablets provide simple, convenient treatment, which will
allow for more accurate dosing,” said Tracey Reynolds, Veterinary
Marketing Manager.
UriCon’s double-scored 50-milligram
chewable tablets allow easy, accurate dosing for most dogs with
a single tablet dosage strength. UriCon’s flexible dosing
with a single size tablet enables veterinarians to stock only one
product to address most of their clients’ needs. UriCon is
highly palatable, beef flavored tablet that will encourage animal
acceptance and simplify administration. The tablets come conveniently
packaged in a choice of 60- or 180-count bottles.
In addition to UriCon,
Neogen’s line of small animal veterinary products includes:
UriKare™, an ammonium chloride
compound in a palatable protein base, which is available in 200
and 400 mg potencies in a powder base, as well as 200 and 400 mg
tablets. UriKare is routinely prescribed as a urinary acidifier.
PanaKare™ Plus Powder, a pancreatic
enzyme concentrate of porcine origin fortified with the fat soluble
vitamins A, D and E.
RenaKare™ Powder, a potassium
supplement that is indicated for use to treat potassium deficient
states in cats and dogs.
ImmunoRegulin®, a Propionibacterium
acnes-based immune stimulant that has been observed to induce macrophage
activation and lymphokine production, enhance cell mediated immunity,
and increase natural killer cell activity.
Neogen Corporation (Nasdaq: NEOG)
develops and markets products dedicated to food and animal safety.
Neogen’s Animal Safety Division markets a complete line of
diagnostics, veterinary instruments, veterinary pharmaceuticals,
nutritional supplements, disinfectants, and rodenticides.
|